Background Cardiovascular events are less prevalent in premenopausal women and women receiving estrogen replacement than in postmenopausal women or men. Endotheliumderived relaxing factor (EDRF) is an important local modula-
173-Estradiol Preserves Endothelial Vasodilator
Function and Limits Low-Density Lipoprotein Oxidation in Hypercholesterolemic Swine John F. Keaney, Jr, MD; Glenn T. Shwaery, MS; Aiming Xu, MD; Robert J. Nicolosi, PhD; Joseph LoscaIzo, MD, PhD; Thomas L. Foxall, PhD; Joseph A. Vita, MD Background Cardiovascular events are less prevalent in premenopausal women and women receiving estrogen replacement than in postmenopausal women or men. Endotheliumderived relaxing factor (EDRF) is an important local modulator of vascular tone, and abnormal endothelial function is related, in part, to the oxidative modification of low-density lipoprotein (LDL). Estrogens possess substantial antioxidant activity and inhibit LDL modification in vitro.
Methods and Results
We investigated the effects of 17k-estradiol (E2) on endothelial vasomotor function in cholesterol-fed miniature swine. Animals underwent ovariectomy or a sham procedure and received E2 or placebo via implant yielding three groups: sham, ovariectomy (E2 placebo), and implant (E2 implant). After 16 weeks, coronary arteries were harvested and endothelial function was examined in vitro. Vessels from the sham and implant groups demonstrated preserved endothelium-dependent relaxation to bradykinin, substance P, and A23187. Vessels from the ovariectomy group exhibited impaired relaxation to bradykinin and substance P (P<.05 versus sham and implant groups) but not to A23187. Plasma E2 levels were strongly correlated with the response to bradykinin (R=.82, P<.001), substance P (R=.64, P<.01), and A23187 (R=.65, P<.01). Compared with the ovariectomy group, LDL derived from the sham and implant groups was markedly resistant to ex vivo oxidation (P<.05), and this effect correlated with preserved endothelium-dependent relaxation to bradykinin (R=.62, P<.03) and substance P (R=.61, P<.03).
Conclusions Thus, E2 preserves endothelial function in cholesterol-fed swine in association with protection of LDL against oxidative modification. These data suggest that E2 may, in part, favorably affect vascular function and coronary artery disease by virtue of its antioxidant properties. (Circulation. 1994;89:2251-2259.)
Key Words * lipoproteins * 170-estradiol * estrogens d relaxing factors * hypercholesterolemia C oronary atherosclerosis and cardiovascular events are less prevalent in women than in age-matched men.' After natural or surgical menopause, women are more likely to develop coronary artery disease than premenopausal women of the same age.2 Estrogen replacement therapy limits the development of coronary artery disease and clinical events in both ovariectomized and postmenopausal women.3 Putative mechanisms responsible for the "protective" role of estrogens include estrogen-mediated effects on lipid metabolism, coagulation parameters, and blood pressure. ' Oral estrogen therapy is associated with increased levels of high-density lipoprotein cholesterol (HDL-C) and decreased low-density lipoprotein cholesterol (LDL-C),4 although large-scale studies indicate that only 25% to 50% of the beneficial effect of estrogen is due to effects on lipoprotein levels.5 '6 The coronary vascular endothelium plays a central role in regulating arterial tone7 and platelet function,8 in part through the actions of endothelium-derived relaxing factor (EDRF). Impairment of endothelium-dependent control of vascular tone develops early in atherosclerosis9 and may contribute to the development of myocardial ischemia.10 Abnormalities in endothelial control of vascular tone may be related, in part, to the oxidative modification of LDL. Exposure of normal arteries to oxidized LDL (ox-LDL) results in impaired endothelium-dependent arterial relaxation,11'12 and ox-LDL may inactivate EDRF directly. 13 Recent evidence suggests that estrogens possess antioxidant activity that is related to the presence of a phenolic ring.14 Modification of LDL by copper ions, monocytes, and endothelial cells in vitro is inhibited by estrogens.15 In phospholipid microsomes, estrogens with a phenolic structure (ie, 17f-estradiol, estriol) inhibit membrane phospholipid peroxidation in proportion to the extent of their membrane incorporation.16 Moreover, membrane estrogens are subject to conversion into their catechol analogues, which possess substantial antioxidant activity.14 There is evidence to suggest that estrogens influence endothelium-dependent regulation of vasomotor tone. In ovariectomized rabbits, 17p-estradiol treatment enhances endothelium-dependent relaxation to acetylcholine, 17 17,3-estradiol) in atherosclerotic monkeys limits acetylcholine-mediated coronary vasoconstriction,21 and the acute administration of ethinyl estradiol has a similar effect. 22 We sought to examine the effect of endogenous and exogenous estrogens on endothelium-dependent arterial relaxation in a hypercholesterolemic swine model. In particular, we hypothesized that estrogens may improve endothelial vasomotor function by virtue of their antioxidant properties. We report the effects of endogenous and exogenous estrogens on endothelium-dependent arterial relaxation as well as effects on plasma lipoproteins and LDL susceptibility to ex vivo oxidation.
Methods Materials
Nitroglycerin was obtained from Solopak Laboratories, and 2,2'-azobis-(2-amidinopropane) hydrochloride (AAPH) was purchased from Kodak, Inc. Glutaraldehyde, formaldehyde, osmium tetroxide, and cacodylate were purchased from Polysciences, Inc. Bradykinin, substance P, calcium ionophore (A23187), and all other compounds were purchased from Sigma Chemical Co. Physiological saline solution (PSS) contained 118.3 mmol/L NaCI, 4.7 After the animals were killed, the hearts were excised and immediately placed into ice-cold PSS. The epicardial coronary arteries were carefully dissected away from the myocardium, and the proximal half of each artery was cut into 3-mm rings (four to six rings per artery), placed in an organ chamber (370C, pH 7.4) containing 20 mL PSS, and suspended between two tungsten stirrups for the measurement of isometric tension with a force transducer (model FT-03, Grass Instrument Co) and a chart recorder (model RS 3800, Gould Instrument Co).
The organ chambers were aerated with 95% 02/5% CG2, and each vessel was gradually stretched to 12 g of resting tension (optimal tension based on preliminary studies) and allowed to equilibrate for 1 hour before the introduction of vasoactive drugs. Vessel contraction was assayed in quiescent rings in response to PSS containing 10, 20, 40, and 80 mmol/L KC1 (substituted for NaCl). In selected vessels, the endothelium was removed by gently rolling the vessel with a wooden applicator stick positioned in the vessel lumen. Vessels were contracted with the thromboxane mimetic U46619 (1 gmol/L), and vascular function was examined by the cumulative addition of bradykinin, calcium ionophore (A23187), substance P, or nitroglycerin. Representative rings were fixed in 3% glutaraldehyde for scanning electron microscopy to confirm the presence or absence of endothelium. With the exception of A23187, the order of agonists was randomized to control for cumulative effects. Vessel ring studies were performed by personnel blinded to hormonal therapy.
Lipoprotein Determination
Blood was drawn into tubes containing EDTA (1.5 mg/mL) and aprotinin (0.05%), and plasma was obtained after lowspeed centrifugation at 4°C. Plasma total cholesterol (TC)26 and triglycerides (TG)27 were quantified using enzymatic methods. HDL-C was measured after phosphotungstic-MgCl2 precipitation of apoprotein B containing very-low-density lipoproteins (VLDL) and LDL." The LDL-C plus VLDL cholesterol (VLDL-C) fraction was determined from the difference between TC and HDL-C as described by Terpstra and colleagues. 29 Lipoprotein Isolation and LDL Susceptibility to Ex Vivo Oxidation LDL (density=1.009 to 1.040 g/mL) was isolated using single-spin gradient ultracentrifugation as described previously. 29 The purity of the LDL fraction was assessed by agarose electrophoresis.30 Standard incubation of LDL to assess susceptibility to oxidation was performed at a LDL concentration of 0.05 mg/mL LDL protein in the presence of 10 ,umol/L AAPH at 37C. LDL oxidative susceptibility was assessed by continuous spectrophotometric monitoring at 234 nm and quantified by the lag-phase duration preceding the formation Plasma lipoprotein profiles from the study animals are given (Table) . Before animals consumed an atherogenic diet, plasma TC, LDL-C plus VLDL-C, HDL-C, and TG levels were 101±7, 43±3, 58±4, and 67±11 mg/dL, respectively. After 16 weeks of dietary treatment, plasma TC, LDL-C plus VLDL-C, and HDL-C increased significantly (P<.05), whereas plasma TG levels were unchanged (Table) . There were no significant differences in plasma lipoprotein profiles among the different treatment groups.
Estrogens and Vascular Function
Animals in the sham, ovariectomy, and implant groups all demonstrated similar coronary artery contractile responses to 1 umol/L U46619 of (mean±SD) 8.7±2.6, 10.6±2.7, and 9.8±3.3 g, respectively (P=NS). 00.
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Bradykinin (log M) FIG 1. Plot demonstrating the effect of endogenous and exogenous estrogens on bradykinin-mediated endothelium-dependent coronary arterial relaxation in hypercholesterolemic swine. Coronary arteries were harvested from animals that were subjected to ovariectomy (a), ovariectomy plus 173-estradiol implant (A), or sham ovariectomy (*) and maintained on an atherogenic diet for 16 weeks. Vessels were harvested, prepared as described in "Methods," and contracted with the thromboxane mimetic U46619 (1 Amol/L). Vessels (Fig 1) .
The coronary vessel response to substance P is shown in Fig 2. Intact coronary arteries from the implant and sham groups displayed significant endothelium-dependent arterial relaxation to substance P with maximal relaxations of 87±5% and 94±8%, respectively (P<.001 versus baseline; Fig 2) . Vessels from animals in the ovariectomy group demonstrated significantly less endothelium-dependent arterial relaxation in response to substance P (maximal response, 43±12%) than vessels from either the sham or implant groups (P<.001; Fig 2) . In the absence of endothelium, there was no significant relaxation in response to substance P (Fig 2) .
The coronary vascular response to the receptorindependent calcium ionophore A23187 is presented in Fig 3. Vessels from all three treatment groups demonstrated significant dose-dependent relaxation in response to increasing doses of A23187 (P<.001 versus baseline). Maximal relaxations observed for the ovariectomy, sham, and implant groups were 82±6%, 95±6%, and 98±4%, respectively. In contrast to the responses seen with bradykinin and substance P, there was no significant difference in endothelium-dependent arterial relaxation on the basis of hormonal status (Fig 3) . In vessels without endothelium, there was no significant relaxation in response to A23187 (Fig 3) .
We investigated smooth muscle cell vasodilator function with the endothelium-independent vasodilator nitroglycerin (Fig 4) . Deendothelialized vessels from all three treatment groups demonstrated significant dosedependent arterial relaxation in response to nitroglycerin with maximal relaxations of 103±4%, 101±3%, and 100±3% in the ovariectomy, sham, and implant groups, respectively (P<.001 versus baseline). There was no significant difference in nitroglycerin-induced arterial 25- 
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-10 -9 -8 -7 -6 A23187 (log M) FIG 3 . Plot demonstrating the effect of endogenous and exogenous estrogens on A23187-mediated endothelium-dependent arterial relaxation in hypercholesterolemic swine coronary arteries. Arteries were harvested from animals that were subjected to ovariectomy (a), ovariectomy plus 17f3-estradiol implant (A), or sham ovariectomy (c) followed by an atherogenic diet for 16 weeks. Vessels were harvested, prepared as described in "Methods," and contracted with the thromboxane mimetic relaxation among the three treatment groups (Fig 4) . The response to nitroglycerin was similar in vessels with endothelium (data not shown). Thus, smooth muscle cell vasodilator function was similar in all three hormonal treatment groups.
Histological Examination
Previous studies in cholesterol-fed animals have demonstrated diminished atherogenesis in cholesterol-fed animals receiving estrogen compared with animals without estrogen.32 '33 In the present study, such an effect might explain group differences in endothelium-dependent vessel relaxation. plasma 173-estradiol levels with a correlation coefficient of .64 (P=.0097). Vessel relaxation to the receptorindependent calcium ionophore A23187 also correlated with the logarithm of plasma 17p-estradiol levels (R=.65, P=.0086), although over a much narrower range of vessel relaxation. Analysis of the slopes for regression lines relating plasma 17f-estradiol levels to vessel relaxation suggests that 1713-estradiol influences vessel relaxation in a rank order of bradykinin> substance P>A23187 in this model (slopes, 41±8, 28±9, and 15±5, respectively). We further examined the relation between endothelium-dependent arterial relaxation and LDL resistance to oxidation in the 12 animals for which data on LDL oxidative resistance were available, and these results are presented in Fig 7. Endothelium-dependent arterial relaxation in response to maximal doses of bradykinin (0.1 1£mol/L) and substance P (3 nmol/L) correlated with LDL resistance to oxidation (lag phase) with correlation coefficients of .62 and .61, respectively (P<.03 for both). LDL resistance to oxidation was not significantly correlated with plasma 17(-estradiol levels (R=.47, P=.123). There was no significant correlation between endothelium-dependent arterial relaxation and plasma lipoproteins (TC, LDL-C plus VLDL-C, HDL-C) or coronary artery intimal proliferation. Discussion
The data presented here demonstrate that endogenous and exogenous estrogens preserve normal endothelium-dependent vasodilation in hypercholesterolemic swine. This preservation of vascular function was unrelated to any alteration in smooth muscle cell function as evidenced by the similar response to both nitroglycerin and KCl among the treatment groups. In this study, estrogens delivered as 173-estradiol via a subcutaneous implant or through intact ovarian function had no significant effects on plasma cholesterol or In the study by Williams and colleagues,21 17f-estradiol treatment was associated with a 33% reduction in plasma cholesterol that may have contributed to the observed effect on coronary vasomotor function. In contrast, the present study demonstrated a significant improvement in eiqdothelium-dependent arterial relaxation without any effect on plasmalipoprotein levels. In women, oral estrogen therapy lowers plasma LDL and raises plasma HDL, whereas transdermal estrogen therapy has no effect.4 Our animals received 17,B-estradiol via subcutaneous implant and thus may have been spared any 17p-estradiol-mediated effects on lipoproteins. Moreover, the similarity in lipoprotein profiles in our implant and sham animals is consistent with observations of other investigators in cholesterol-fed rabbits35 and monkeys33'36 treated with subcutaneous estrogen or estrogen-progesterone combinations.
In this study, we observed no significant association between 173-estradiol levels and coronary artery intimal proliferation, whereas Williams and colleagues2' observed less intimal proliferation in estrogen-treated animals. It is possible that our study did not contain a sufficient number of animals to demonstrate such an association. Alternatively, it is also possible that similar lipoprotein levels among the treatment groups produced similar degrees of intimal proliferation with 16 weeks of cholesterol feeding.
In Modified LDL may also affect EDRF action in atherosclerosis through its effects on leukocyte recruitment. Oxidized LDL is chemotactic for monocytes and prevents macrophage egress from atherosclerotic vessels. 44 Vessel wall macrophages are a potential source of oxygen-derived free radicals45 that may serve as a source of continued LDL oxidation" and EDRF inactivation. 47 Moreover, the ox-LDL so formed may contribute to continued macrophage recruitment and may inactivate EDRF directly. '3 Abnormalities in endothelium-dependent relaxation may also be related to the inflammatory response associated with atherosclerosis and hypercholesterolemia. Several 
